No Data
No Data
Idexx Laboratories Has Launched Catalyst Pancreatic Lipase Test For Canine And Feline Patients Suspected Of Pancreatitis, It Will Be Available In US And Canada This September, With Global Rollout To Over 70,000 Installed Base Planned In Q4 Of 2024
Idexx Laboratories Has Launched Catalyst Pancreatic Lipase Test For Canine And Feline Patients Suspected Of Pancreatitis, It Will Be Available In US And Canada This September, With Global Rollout To O
IDEXX Expands Test Menu for the Catalyst Platform to Support Veterinarians Globally in Diagnosing Pancreatitis
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announces the launch of the Catalyst Pancreatic Lipase Test,...
Will Weakness in IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Stock Prove Temporary Given Strong Fundamentals?
Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Might Deserve Your Attention Today
IDEXX Laboratories Inc(IDXX.US) Director Sells US$108.16K in Common Stock
$IDEXX Laboratories Inc(IDXX.US)$ Director Claflin Bruce L. sold 200 shares of common stock on May 17, 2024 at an average price of $540.8 for a total value of $108.16K.Source: Announcement What is sta
$100 Invested In This Stock 15 Years Ago Would Be Worth $2,500 Today
IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 15 years by 11.59% on an annualized basis producing an average annual return of 24.04%. Currently, IDEXX Laboratories has a m
No Data